000 | 01197 a2200337 4500 | ||
---|---|---|---|
005 | 20250513051113.0 | ||
264 | 0 | _c19931210 | |
008 | 199312s 0 0 eng d | ||
022 | _a0091-2700 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRosenthal, J | |
245 | 0 | 0 |
_aLipid metabolism: implications of alpha 1-blockade. _h[electronic resource] |
260 |
_bJournal of clinical pharmacology _cSep 1993 |
||
300 |
_a883-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAdrenergic alpha-Antagonists _xpharmacology |
650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
650 | 0 | 4 | _aBenzothiadiazines |
650 | 0 | 4 |
_aCardiovascular Diseases _xprevention & control |
650 | 0 | 4 |
_aCholesterol, HDL _xblood |
650 | 0 | 4 |
_aCholesterol, LDL _xblood |
650 | 0 | 4 | _aDiuretics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLipid Metabolism |
650 | 0 | 4 |
_aLipoproteins, LDL _xbiosynthesis |
650 | 0 | 4 |
_aLipoproteins, VLDL _xbiosynthesis |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 |
_aReceptors, Adrenergic, alpha _xdrug effects |
650 | 0 | 4 |
_aSodium Chloride Symporter Inhibitors _xpharmacology |
773 | 0 |
_tJournal of clinical pharmacology _gvol. 33 _gno. 9 _gp. 883-7 |
|
999 |
_c7900576 _d7900576 |